Financial statements Biocontract
Balance sheet data of BIOCONTRACT
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|---|
| Total assets | 8 910 205,07 | 9 247 824,50 | 9 224 180,76 | 10 321 003,34 | 10 333 194,41 | 10 329 627,52 |
| A. Fixed assets | 8 244 093,42 | 9 247 814,64 | 9 209 147,34 | 10 318 968,21 | 10 318 968,21 | 10 318 968,21 |
| B. Current assets | 666 111,65 | 9,86 | 15 033,42 | 2 035,13 | 14 226,20 | 10 659,31 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 8 910 205,07 | 9 247 824,50 | 9 224 180,76 | 10 321 003,34 | 10 333 194,41 | 10 329 627,52 |
| A. Equity | 5 141 769,94 | 6 022 322,98 | 5 594 384,02 | 6 919 170,17 | 6 719 647,35 | 6 456 935,14 |
| B. Liabilities and provisions for liabilities | 3 768 435,13 | 3 225 501,52 | 3 629 796,74 | 3 401 833,17 | 3 613 547,06 | 3 872 692,38 |
| I. Long-term liabilities | 2 350 000,00 | 2 350 000,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 418 435,13 | 875 501,52 | 3 629 796,74 | 3 401 833,17 | 3 613 547,06 | 3 872 692,38 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.